Shandong Weigao Orthopaedic Device Co. Ltd. A Asset Resilience Ratio

Latest as of March 2026: 6.28%

Shandong Weigao Orthopaedic Device Co. Ltd. A asset resilience ratio. Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has an Asset Resilience Ratio of 6.28% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688161 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥325.88 Million
≈ $47.69 Million USD Cash + Short-term Investments

Total Assets

CN¥5.19 Billion
≈ $759.56 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shandong Weigao Orthopaedic Device Co. Ltd. A (2021–2025)

Asset resilience ratio of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2021 to 2025. This chart shows how Shandong Weigao Orthopaedic Device Co. Ltd. A's Asset Resilience Ratio has changed over time. Read 688161 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shandong Weigao Orthopaedic Device Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688161 total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥325.88 Million 6.28%
Total Liquid Assets CN¥325.88 Million 6.28%

Asset Resilience Insights

  • Limited Liquidity: Shandong Weigao Orthopaedic Device Co. Ltd. A maintains only 6.28% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shandong Weigao Orthopaedic Device Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shandong Weigao Orthopaedic Device Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
TAIDOC TECHNOLOGY CORP
TW:4736
Medical Devices 23.03%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%

Shandong Weigao Orthopaedic Device Co. Ltd. A Asset Resilience Ratio by Year (2021–2025)

Shandong Weigao Orthopaedic Device Co. Ltd. A asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Shandong Weigao Orthopaedic Device Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.05% CN¥306.15 Million
≈ $44.80 Million
CN¥5.06 Billion
≈ $740.59 Million
+4.22pp
2024-12-31 1.83% CN¥90.54 Million
≈ $13.25 Million
CN¥4.95 Billion
≈ $724.05 Million
+1.64pp
2021-12-31 0.19% CN¥10.00 Million
≈ $1.46 Million
CN¥5.40 Billion
≈ $790.67 Million
--
pp = percentage points

About Shandong Weigao Orthopaedic Device Co. Ltd. A

SHG:688161 China Medical Devices
Market Cap
$1.22 Billion
CN¥8.32 Billion CNY
Market Cap Rank
#7805 Global
#1714 in China
Share Price
CN¥20.80
Change (1 day)
-0.91%
52-Week Range
CN¥20.15 - CN¥32.15
All Time High
CN¥104.04
About

Shandong Weigao Orthopaedic Device Co., Ltd. engages in research, development, production, and sales of orthopedic medical devices. The company offers orthopedic implantable medical devices and orthopedic surgical instruments. It also provides spinal products, such as internal fixation systems for the cervical and thoracic/lumbar spine, and interbody fusion devices; trauma-related products includ… Read more